Cargando…
Finding effective biomarkers for pediatric traumatic brain injury
As traumatic brain injury (TBI) continues to affect children and young adults worldwide, research on reliable biomarkers grows as a possible aid in determining the severity of injury. However, many studies have revealed that diverse biomarkers such as S100B and myelin basic protein (MBP) have many l...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126274/ https://www.ncbi.nlm.nih.gov/pubmed/30276288 http://dx.doi.org/10.4103/2394-8108.192518 |
_version_ | 1783353309250191360 |
---|---|
author | Glushakova, Olena Y Glushakov, Alexander V Hayes, Ronald L |
author_facet | Glushakova, Olena Y Glushakov, Alexander V Hayes, Ronald L |
author_sort | Glushakova, Olena Y |
collection | PubMed |
description | As traumatic brain injury (TBI) continues to affect children and young adults worldwide, research on reliable biomarkers grows as a possible aid in determining the severity of injury. However, many studies have revealed that diverse biomarkers such as S100B and myelin basic protein (MBP) have many limitations, such as their elevated normative concentrations in young children. Therefore, the results of these studies have yet to be translated to clinical applications. However, despite the setbacks of research into S100B and MBP, investigators continue to research viable biomarkers, notably glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1), as possible aids in medical decision making. Studies have revealed that GFAP and UCH-L1 actually are better predictors of injury progression than the before-mentioned biomarkers S100B and MBP. In addition, UCH-L1 has demonstrated an ability to detect injury while CT is negative, suggesting an ability to detect acute intracranial lesions. Here, we evaluate research testing levels of GFAP and UCH-L1 on children diagnosed with TBI and compare our results to those of other tested biomarkers. In a recent study done by Hayes et al., GFAP and UCH-L1 demonstrated the potential to recognize children with the possibility of poor outcome, allowing for more specialized treatments with clinical and laboratory applications. Although studies on GFAP and UCH-L1 have for the most part warranted positive results, further studies will be needed to confirm their role as reliable markers for pediatric TBI. |
format | Online Article Text |
id | pubmed-6126274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-61262742018-10-01 Finding effective biomarkers for pediatric traumatic brain injury Glushakova, Olena Y Glushakov, Alexander V Hayes, Ronald L Brain Circ Review Article As traumatic brain injury (TBI) continues to affect children and young adults worldwide, research on reliable biomarkers grows as a possible aid in determining the severity of injury. However, many studies have revealed that diverse biomarkers such as S100B and myelin basic protein (MBP) have many limitations, such as their elevated normative concentrations in young children. Therefore, the results of these studies have yet to be translated to clinical applications. However, despite the setbacks of research into S100B and MBP, investigators continue to research viable biomarkers, notably glial fibrillary acidic protein (GFAP) and ubiquitin C-terminal hydrolase L1 (UCH-L1), as possible aids in medical decision making. Studies have revealed that GFAP and UCH-L1 actually are better predictors of injury progression than the before-mentioned biomarkers S100B and MBP. In addition, UCH-L1 has demonstrated an ability to detect injury while CT is negative, suggesting an ability to detect acute intracranial lesions. Here, we evaluate research testing levels of GFAP and UCH-L1 on children diagnosed with TBI and compare our results to those of other tested biomarkers. In a recent study done by Hayes et al., GFAP and UCH-L1 demonstrated the potential to recognize children with the possibility of poor outcome, allowing for more specialized treatments with clinical and laboratory applications. Although studies on GFAP and UCH-L1 have for the most part warranted positive results, further studies will be needed to confirm their role as reliable markers for pediatric TBI. Medknow Publications & Media Pvt Ltd 2016 2016-10-18 /pmc/articles/PMC6126274/ /pubmed/30276288 http://dx.doi.org/10.4103/2394-8108.192518 Text en Copyright: © 2016 Brain Circulation http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Glushakova, Olena Y Glushakov, Alexander V Hayes, Ronald L Finding effective biomarkers for pediatric traumatic brain injury |
title | Finding effective biomarkers for pediatric traumatic brain injury |
title_full | Finding effective biomarkers for pediatric traumatic brain injury |
title_fullStr | Finding effective biomarkers for pediatric traumatic brain injury |
title_full_unstemmed | Finding effective biomarkers for pediatric traumatic brain injury |
title_short | Finding effective biomarkers for pediatric traumatic brain injury |
title_sort | finding effective biomarkers for pediatric traumatic brain injury |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126274/ https://www.ncbi.nlm.nih.gov/pubmed/30276288 http://dx.doi.org/10.4103/2394-8108.192518 |
work_keys_str_mv | AT glushakovaolenay findingeffectivebiomarkersforpediatrictraumaticbraininjury AT glushakovalexanderv findingeffectivebiomarkersforpediatrictraumaticbraininjury AT hayesronaldl findingeffectivebiomarkersforpediatrictraumaticbraininjury |